Shanghai, China – 9 February, 2015 - Shanghai MicroPort Access Medtech Co ("MicroPort Access"), a subsidiary of Shanghai MicroPort Medical (Group) Co ("MicroPort"), recently gained a registration certificate for its Angiographic Catheter from China Food and Drug Administration ("CFDA"). This Angiographic Catheter includes six additional distal end configurations, such as coronary artery LRS, RH and Cobra.
MicroPort Access Angiographic Catheter is used for coronary artery angiography and peripheral vascular angiography. Its distal tip is designed with innovative "Full-radius" structure. Its extra soft material can reduce the damage of blood vessel and provide better cross ability. With six distal end configurations, the Angiographic Catheter offers more options for surgeons and is expected to increase its market share in the future.